alagebrium has been researched along with atorvastatin in 1 studies
| Studies (alagebrium) | Trials (alagebrium) | Recent Studies (post-2010) (alagebrium) | Studies (atorvastatin) | Trials (atorvastatin) | Recent Studies (post-2010) (atorvastatin) |
|---|---|---|---|---|---|
| 83 | 10 | 31 | 7,420 | 2,058 | 3,782 |
| Protein | Taxonomy | alagebrium (IC50) | atorvastatin (IC50) |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.0064 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.0002 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0002 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0054 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 4.3 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, B; Li, Z; Yang, P | 1 |
1 other study(ies) available for alagebrium and atorvastatin
| Article | Year |
|---|---|
Effect of atorvastatin on AGEs-induced injury of cerebral cortex via inhibiting NADPH oxidase -NF-κB pathway in ApoE
Topics: Amyloid beta-Peptides; Animals; Anticholesteremic Agents; Apolipoproteins E; Atorvastatin; Cerebral Cortex; Diet, High-Fat; Gene Expression Regulation; Glycation End Products, Advanced; Immunohistochemistry; Inflammation; Male; Mice; Mice, Knockout; NADPH Oxidases; Neurons; Oxidative Stress; Receptor for Advanced Glycation End Products; Signal Transduction; Thiazoles; Transcription Factor RelA | 2020 |